Immunobiological barriers to xenotransplantation

David K C Cooper, Burcin Ekser, A. Joseph Tector

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Binding of natural anti-pig antibodies in humans and nonhuman primates to carbohydrate antigens expressed on the transplanted pig organ, the most important of which is galactose-α1,3-galactose (Gal), activate the complement cascade, which results in destruction of the graft within minutes or hours, known as hyperacute rejection. Even if antibody is removed from the recipient's blood by plasmapheresis, recovery of antibody is associated with acute humoral xenograft rejection. If immunosuppressive therapy is inadequate, the development of high levels of T cell-dependent elicited anti-pig IgG similarly results in graft destruction, though classical acute cellular rejection is rarely seen. Vascular endothelial activation by low levels of anti-nonGal antibody, coupled with dysregulation of the coagulation-anticoagulation systems between pigs and primates, leads to a thrombotic microangiopathy in the graft that may be associated with a consumptive coagulopathy in the recipient. The most successful approach to overcoming these barriers is by genetically-engineering the pig to provide it with resistance to the human humoral and cellular immune responses and to correct the coagulation discrepancies between the two species. Organs and cells from pigs that (i) do not express the important Gal antigen, (ii) express a human complement-regulatory protein, and (iii) express a human coagulation-regulatory protein, when combined with an effective immunosuppressive regimen, have been associated with prolonged pig graft survival in nonhuman primates.

Original languageEnglish (US)
Pages (from-to)211-216
Number of pages6
JournalInternational Journal of Surgery
Volume23
DOIs
StatePublished - Nov 1 2015

Fingerprint

Heterologous Transplantation
Swine
Galactose
Primates
Immunosuppressive Agents
Transplants
Anti-Idiotypic Antibodies
Thrombotic Microangiopathies
Antigens
Plasmapheresis
Antibodies
Graft Survival
Humoral Immunity
Heterografts
Cellular Immunity
Blood Vessels
Complement System Proteins
Carbohydrates
T-Lymphocytes

Keywords

  • Organ donation
  • Pig
  • Transplantation, islets
  • Transplantation, organs
  • Xenotransplantation

ASJC Scopus subject areas

  • Surgery

Cite this

Immunobiological barriers to xenotransplantation. / Cooper, David K C; Ekser, Burcin; Tector, A. Joseph.

In: International Journal of Surgery, Vol. 23, 01.11.2015, p. 211-216.

Research output: Contribution to journalArticle

Cooper, David K C ; Ekser, Burcin ; Tector, A. Joseph. / Immunobiological barriers to xenotransplantation. In: International Journal of Surgery. 2015 ; Vol. 23. pp. 211-216.
@article{08f7d9217d4c41cd87fb9814cd3054a3,
title = "Immunobiological barriers to xenotransplantation",
abstract = "Binding of natural anti-pig antibodies in humans and nonhuman primates to carbohydrate antigens expressed on the transplanted pig organ, the most important of which is galactose-α1,3-galactose (Gal), activate the complement cascade, which results in destruction of the graft within minutes or hours, known as hyperacute rejection. Even if antibody is removed from the recipient's blood by plasmapheresis, recovery of antibody is associated with acute humoral xenograft rejection. If immunosuppressive therapy is inadequate, the development of high levels of T cell-dependent elicited anti-pig IgG similarly results in graft destruction, though classical acute cellular rejection is rarely seen. Vascular endothelial activation by low levels of anti-nonGal antibody, coupled with dysregulation of the coagulation-anticoagulation systems between pigs and primates, leads to a thrombotic microangiopathy in the graft that may be associated with a consumptive coagulopathy in the recipient. The most successful approach to overcoming these barriers is by genetically-engineering the pig to provide it with resistance to the human humoral and cellular immune responses and to correct the coagulation discrepancies between the two species. Organs and cells from pigs that (i) do not express the important Gal antigen, (ii) express a human complement-regulatory protein, and (iii) express a human coagulation-regulatory protein, when combined with an effective immunosuppressive regimen, have been associated with prolonged pig graft survival in nonhuman primates.",
keywords = "Organ donation, Pig, Transplantation, islets, Transplantation, organs, Xenotransplantation",
author = "Cooper, {David K C} and Burcin Ekser and Tector, {A. Joseph}",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.ijsu.2015.06.068",
language = "English (US)",
volume = "23",
pages = "211--216",
journal = "International Journal of Surgery",
issn = "1743-9191",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Immunobiological barriers to xenotransplantation

AU - Cooper, David K C

AU - Ekser, Burcin

AU - Tector, A. Joseph

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Binding of natural anti-pig antibodies in humans and nonhuman primates to carbohydrate antigens expressed on the transplanted pig organ, the most important of which is galactose-α1,3-galactose (Gal), activate the complement cascade, which results in destruction of the graft within minutes or hours, known as hyperacute rejection. Even if antibody is removed from the recipient's blood by plasmapheresis, recovery of antibody is associated with acute humoral xenograft rejection. If immunosuppressive therapy is inadequate, the development of high levels of T cell-dependent elicited anti-pig IgG similarly results in graft destruction, though classical acute cellular rejection is rarely seen. Vascular endothelial activation by low levels of anti-nonGal antibody, coupled with dysregulation of the coagulation-anticoagulation systems between pigs and primates, leads to a thrombotic microangiopathy in the graft that may be associated with a consumptive coagulopathy in the recipient. The most successful approach to overcoming these barriers is by genetically-engineering the pig to provide it with resistance to the human humoral and cellular immune responses and to correct the coagulation discrepancies between the two species. Organs and cells from pigs that (i) do not express the important Gal antigen, (ii) express a human complement-regulatory protein, and (iii) express a human coagulation-regulatory protein, when combined with an effective immunosuppressive regimen, have been associated with prolonged pig graft survival in nonhuman primates.

AB - Binding of natural anti-pig antibodies in humans and nonhuman primates to carbohydrate antigens expressed on the transplanted pig organ, the most important of which is galactose-α1,3-galactose (Gal), activate the complement cascade, which results in destruction of the graft within minutes or hours, known as hyperacute rejection. Even if antibody is removed from the recipient's blood by plasmapheresis, recovery of antibody is associated with acute humoral xenograft rejection. If immunosuppressive therapy is inadequate, the development of high levels of T cell-dependent elicited anti-pig IgG similarly results in graft destruction, though classical acute cellular rejection is rarely seen. Vascular endothelial activation by low levels of anti-nonGal antibody, coupled with dysregulation of the coagulation-anticoagulation systems between pigs and primates, leads to a thrombotic microangiopathy in the graft that may be associated with a consumptive coagulopathy in the recipient. The most successful approach to overcoming these barriers is by genetically-engineering the pig to provide it with resistance to the human humoral and cellular immune responses and to correct the coagulation discrepancies between the two species. Organs and cells from pigs that (i) do not express the important Gal antigen, (ii) express a human complement-regulatory protein, and (iii) express a human coagulation-regulatory protein, when combined with an effective immunosuppressive regimen, have been associated with prolonged pig graft survival in nonhuman primates.

KW - Organ donation

KW - Pig

KW - Transplantation, islets

KW - Transplantation, organs

KW - Xenotransplantation

UR - http://www.scopus.com/inward/record.url?scp=84951573696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951573696&partnerID=8YFLogxK

U2 - 10.1016/j.ijsu.2015.06.068

DO - 10.1016/j.ijsu.2015.06.068

M3 - Article

VL - 23

SP - 211

EP - 216

JO - International Journal of Surgery

JF - International Journal of Surgery

SN - 1743-9191

ER -